References
- 1. Han JC, Lawlor DA, Kimm YS. Childhood Obesity. Lancet. 2010;375(9727):1737-48. DOI: 10.1016/S0140-6736(10)60171-710.1016/S0140-6736(10)60171-7
- 2. De Onis M, Blossner M, Borghi E. Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr. 2010;92(5):1257–64. DOI: 10.3945/ajcn.2010.2978610.3945/ajcn.2010.29786
- 3. Chirita-Emandi A, Barbu CG, Cinteza EE, Chesaru BI, Gafencu M, Mocanu V, et al. Overweight and Under-weight Prevalence Trends in Children from Romania – Pooled Analysis of Cross-Sectional Studies between 2006 and 2015. Obes Facts. 2016;9(3):2016-20. DOI: 10.1159/00044417310.1159/000444173
- 4. NCD Risk Factor Collaboration (NCD-RisC). Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants. Int J Epidemiol. 2018;0:1–21 in press.
- 5. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, over-weight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-2642. DOI: 10.1016/S0140-6736(17)32129-310.1016/S0140-6736(17)32129-3
- 6. Bray GA, Heisel WE, Afshin A, Jensen MD, Dietz WH, Long M et al. The Science of Obesity Management: an Endocrine Society Scientific Statement. Endocr Rev 2018;39:1-54. DOI: 10.1210/er.2017-0025310.1210/er.2017-00253
- 7. Levy E, Saenger AK, Steff MW, Delvin E. Pediatric Obesity and Cardiometabolic Disorders: Risk Factors and Biomarkers. EJIFCC 2017;28(1):6-24.
- 8. Zhu ZL, Yang QM, Li C, Chen J, Xiang M, Chen MM et al. Identification of biomarkers for childhood obesity based on expressional correlation and functional similarity. Mol Med Rep. 2018;17(1):109-16.
- 9. Sikaris KA. The Clinical Biochemistry of Obesity. Clin Biochem Rev. 2004;25(3):165-81.
- 10. Socha P, Hellmuth C, Gruszfeld D, Demmelmair H, Rzehak P, Grote V, et al. Endocrine and Metabolic Biomarkers Predicting Early Childhood Obesity Risk. Nestle Nutr Inst Workshop Ser. 2016;85:81-8. DOI: 10.1159/000439489
- 11. Cinteza M - Can we Cure Type 2 Diabetes Mellitus? Maybe Yes !...- Maedica (Bucharest). 2013 Sep;8(3):229-30.
- 12. Venner AA, Lyon ME, Doyle-Baker PK. Leptin: a Potential Biomarker for Childhood Obesity? Clin Biochem. 2006 Nov;39(11):1047-56. DOI: 10.1016/j.clinbiochem.2006.07.01010.1016/j.clinbiochem.2006.07.010
- 13. Yigitbasi T, Baskin Y, Akgol E, Kocal GC, Ellidokuz H. Association of ischemia-modified albumin with oxidative stress status and insulin resistance in obese patients. Rev Romana Med Lab. 2017;25(3):255-63. DOI: 10.1515/rrlm-2017-002010.1515/rrlm-2017-0020
- 14. Sandor R, Leucuta D, Dronca E, Niculae A, Cret V, Silaghi C, et al. Low Serum Paraoxonase-1 Lactonase and Arylesterase Activities in Obese Children and Adolescents. Rev Romana Med Lab. 2015;23(4):385-95. DOI: 10.1515/rrlm-2015-003810.1515/rrlm-2015-0038
- 15. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2018 Jan;41(Suppl 1):S1-S151.
- 16. Cornell S. Comparison of the diabetes guidelines from the ADA/EASD and the AACE/ACE. J Am Pharm Assoc (2003). 2017 Mar - Apr;57(2):261-265.
- 17. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyper-glycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015 Jan;38(1):140-9. DOI: 10.2337/dc14-244110.2337/dc14-2441
- 18. Garvey WT, Ryan DH, Bohannon NJ, Kushner RF, Rueger M, Dvorak RV, et al. Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended release. Diabetes Care. 2014 Dec;37(12):3309-16. DOI: 10.2337/dc14-093010.2337/dc14-0930